|
Kanamycin Injection
» Kanamycin Injection contains an amount of Kanamycin Sulfate equivalent to not less than 90.0 percent and not more than 115.0 percent of the labeled amount of kanamycin (C18H36N4O11). It contains suitable buffers and preservatives.
Packaging and storage
Preserve in single-dose or in multiple-dose containers, preferably of Type I or Type III glass.
Identification
A:
B:
Bacterial endotoxins
Sterility
pH
Particulate matter
Other requirements
It meets the requirements under Injections
Assay
Mobile phase, Resolution solution, Standard preparation, and Chromatographic system
Proceed as directed in the Assay under Kanamycin Sulfate.
Assay preparation
Dilute an accurately measured volume of Injection quantitatively, and stepwise if necessary, with water to obtain a solution having a concentration of about 0.006 mg of kanamycin per mL.
Procedure
Proceed as directed in the Assay under Kanamycin Sulfate. Calculate the quantity, in mg, of kanamycin (C18H36N4O11) in each mL of the Injection taken by the formula:
(L / D)(CP / 1000)(rU / rS)
in which L is the labeled quantity, in mg, of kanamycin in each mL of the Injection; D is the concentration, in mg per mL, of kanamycin in the Assay preparation, on the basis of the labeled quantity per mL and the extent of dilution; and the other terms are as defined therein.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
Chromatographic Column
USP32NF27 Page 2735
Pharmacopeial Forum: Volume No. 26(6) Page 1554
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.
|